CCL2 and systemic lupus erythematosus: Although MSCs suppress normal B-cell proliferation, differentiation, and antibody secretion, CCL2 silencing blocks the suppressive effects on B cells in the MSCs of systemic lupus erythematosus (SLE) patients (Che et al., 2014; Yang et al., 2021a).